Suppr超能文献

肥胖在多囊卵巢综合征发展中的作用。

The role of obesity in the development of polycystic ovary syndrome.

机构信息

Laboratory of Ovarian Physio-pathology, Center of Pharmacological and Botanical Studies, School of Medicine, University of Buenos Aires, Argentina.

出版信息

Curr Pharm Des. 2012;18(17):2482-91. doi: 10.2174/13816128112092482.

Abstract

Polycystic Ovary Syndrome (PCOS) is one of the common endocrine diseases that affects women in their reproductive age. PCOS has diverse clinical implications that include reproductive (infertility, hyperandrogenism, hirsutism), metabolic (insulin resistance, impaired glucose tolerance, type 2 diabetes mellitus, cardiovascular diseases) and psychological features (increased anxiety, depression and worsened quality of life). The exact patho-physiology of PCOS is complex and remains largely unclear. The prevalence of PCOS is estimated at 4-18%, depending on diverse factors discussed ahead. The phenotype varies widely depending on life stage, genotype, ethnicity and environmental factors including lifestyle and body weight. During the last decades, obesity and excess weight are major chronic diseases all around the word. Obesity increases some features of PCOS such as hyperandrogenism, hirsutism, infertility and pregnancy complications. Both obesity and insulin resistance increase diabetes mellitus type 2 and cardiovascular diseases. Moreover, obesity impairs insulin resistance and exacerbates reproductive and metabolic features of PCOS. It is well known that obesity is associated with anovulation, pregnancy loss and late pregnancy complications (pre-eclampsia, gestational diabetes). Obesity in PCOS is also linked to failure or delayed response to the various treatments including clomiphene citrate, gonadotropins and laparoscopic ovarian diathermy. It has been reported that, after losing as little as 5 % of initial body weight obese women with PCOS improved spontaneous ovulation rates and spontaneous pregnancy. Therefore, the weight loss prior to conception improves live birth rate in obese women with or without PCOS. The treatment of obesity may include lifestyle therapy (diet and exercise), pharmacological treatment and bariatric surgery. In summary, weight loss is considered the first-line therapy in obese women with PCOS. In the present review, the consequence and treatment of obesity in women with PCOS are discussed.

摘要

多囊卵巢综合征(PCOS)是影响育龄妇女的常见内分泌疾病之一。PCOS 具有多种临床表现,包括生殖(不孕、高雄激素血症、多毛症)、代谢(胰岛素抵抗、糖耐量受损、2 型糖尿病、心血管疾病)和心理特征(焦虑增加、抑郁和生活质量恶化)。PCOS 的确切病理生理学非常复杂,目前仍不清楚。PCOS 的患病率估计为 4-18%,具体取决于前面讨论的各种因素。表型差异很大,取决于生命阶段、基因型、种族和环境因素,包括生活方式和体重。在过去几十年中,肥胖和超重是全世界的主要慢性疾病。肥胖会增加 PCOS 的一些特征,如高雄激素血症、多毛症、不孕和妊娠并发症。肥胖和胰岛素抵抗都会增加 2 型糖尿病和心血管疾病的风险。此外,肥胖会加重胰岛素抵抗,并使 PCOS 的生殖和代谢特征恶化。众所周知,肥胖与 PCOS 的无排卵、妊娠丢失和晚期妊娠并发症(子痫前期、妊娠期糖尿病)有关。PCOS 中的肥胖也与对各种治疗的失败或延迟反应有关,包括克罗米酚、促性腺激素和腹腔镜卵巢电凝术。据报道,肥胖的 PCOS 女性体重减轻 5%就可以提高自发性排卵率和自发性妊娠率。因此,肥胖女性在受孕前减轻体重可以提高活产率,无论是否患有 PCOS。肥胖的治疗方法包括生活方式治疗(饮食和运动)、药物治疗和减重手术。总之,体重减轻被认为是肥胖的 PCOS 女性的一线治疗方法。在本次综述中,讨论了肥胖对 PCOS 女性的影响和治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验